Prevalence Of Glycoprotein Research Articles

Increased Prevalence of Glycoprotein IIb/IIIa Leu33Pro Polymorphism in Term Infants with Grade I Intracranial Haemorrhage

The prevalence rates of the platelet glycoprotein IIb/IIIa Leu33Pro allele (PLA2), and factor V G1691A Leiden mutation were determined in 109 appropriate for gestational age neonates with grade I intraventricular haemorrhage (IVH) and in 118 IVH-free control infants. The PLA2 allele frequency was 16.4 % in the group of full-term infants with grade I IVH, while it was 9.5 % in the relevant controls (p < 0.005); there was no difference in the PLA allele frequencies on comparing the IVH affected (8.34 %) and unaffected (9.2 %) premature infants. By contrast, the factor V Leiden allele frequency was increased only in the subgroup of premature infants with grade I IVH as compared with the appropriate premature controls (9.25 % vs. 3.34 %, respectively, p < 0.005). These data suggest that besides the factor V Leiden mutation, the PLA2 allele, which has already been suggested to have a role in neonatal alloimmune thrombocytopenia and certain subtypes of adult stroke, can have significance in the development of the events of IVH.

Human cytomegalovirus glycoprotein N genotypes in AIDS patients

Human cytomegalovirus (HCMV) clinical isolates display genetic polymorphisms that are supposed to be implicated in HCMV-induced immunopathogenesis. Open reading frame UL73, encoding for the envelope glycoprotein N, shows four distinct genomic variants (gN-1, 2, 3, 4). This report analysed the distribution of glycoprotein N genotypes in 29 AIDS patients and 50 solid-organ transplant recipients compared with 111 immunocompetent individuals. HIV patients exhibited a prevalence of HCMV strains with the gN-1 genotype, which seem to replicate favourably in immunocompromised hosts.